Author: NVGCT

We would like to share the following opportunity for (aspiring) postdoctoral researchers in cell and gene therapy.

BEYOND is a new Marie Skłodowska-Curie COFUND postdoctoral program coordinated by Fondazione Telethon and SR-Tiget and funded by the European Commission. Over the next five years, the program will recruit 35 outstanding postdoctoral fellows across leading European institutions in Italy, Sweden, the United Kingdom, and Slovenia.
BEYOND offers an interdisciplinary training environment combining cutting-edge research in advanced cell and gene therapies with structured training on ATMP development, transferable skills, intersectoral exposure, and tailored career development support.

The BEYOND call is now open, closing on the 20 of August 2026. Further information is available on the programme website: https://www.beyond-cofund.eu/.

We would like to highlight the following conference that may be of interest to our community: the 3rd RNA Horizons Conference will take place on 16-18 September 2026 in Munich, Germany. This gathering is dedicated to advancing the transformative potential of RNA technology in cancer medicine. It will explore cutting-edge advancements in RNA system biology as well as novel therapeutic avenues of RNA therapeutics, and it will foster interdisciplinary collaboration.

Some of the key areas that will be covered:

• RNA Processing & Mis-Splicing in Human Disease
• Epitranscriptomic Regulation in Cancer, Immunity & Aging
• RNA-Based Immune Modulation
• mRNA Vaccines & Personalized RNA Immunotherapy
• RNA Therapeutics for Genetic & Rare Disorders
• RNA Biomarkers & Precision Medicine
• RNA-Mediated Tumor Microenvironment Modulation
• RNA Delivery Technologies
• Non-coding RNAs as Drug Targets
• AI in RNA Medicine

To learn more, please visit www.rnahorizons.com.

The NVGCT Greiner Award is a yearly awarded prize for the best Dutch thesis on gene or cell therapy research. At our upcoming Annual Conference (25-26 June 2026) we will grant this award to a thesis that was successfully defended in 2025. Written nominations by the thesis promotor and/or co-promotor can be addressed to the NVGCT scientific committee via Dr. Massimiliano Caiazzo (letter and pdf of the thesis). The call for nominations for the Greiner Award 2025 will close on 1 April 2026. More information and a list of previous Greiner Award winners can be found here.

The NVGCT Annual Conference in 2026 will take place on 25-26 June 2026 at de Werelt, Lunteren. Make sure to save the date, and keep an eye on this page and our socials to stay up-to-date about the program and registration.

You can register here

Abstract submission is now open. Deadline for sending in your abstracts is April 1st, 2026.

Het dagblad Trouw heeft in samenwerking met de VSOP een bijlage gepubliceerd waarin de lezer geinformeerd wordt over gen- en celtherapie in Nederland: de stand van zaken, en het belang van samenwerking tussen wetenschap, overheid en samenleving. De bijlage bevat 3 interviews: met onze NVGCT voorzitter Prof. Victor van Beusechem, een patient, en een arts. Gezamenlijk lichten zij toe hoe onderzoekers, artsen en patiënten samen werken aan de toekomst van zorg. Hoe dichtbij zijn we bij echte toepassingen voor patiënten? En wat is ervoor nodig om baanbrekend onderzoek sneller naar de kliniek te brengen?

De volledige bijlage kan hier gelezen worden. De afzonderlijke artikelen zijn te bereiken via onderstaande links:

Gaan we met gentherapie van behandelen naar genezen?

Leven zonder spuit Hoe gentherapie je leven kan veranderen

Hoop voor de toekomst: gentherapie bij Hemofilie